ARTICLE | Company News
Abbott infectious news
July 4, 2005 7:00 AM UTC
On June 24, the Brazilian Ministry of Health gave ABT 10 days to reduce the price of its Kaletra lopinavir/ritonavir for HIV, or the government will grant a compulsory license to a generic manufactur...